PRESS RELEASE published on 03/14/2025 at 07:30, 1 year 4 months ago Dermapharm Holding SE increases revenue as projected and exceeds guidance for adjusted consolidated EBITDA Dermapharm Holding SE reports 4.0% increase in consolidated revenue to EUR 1,180.8 million for 2024 with adjusted EBITDA rising by 1.7% to EUR 315.6 million. Strong growth in branded pharmaceuticals segment Financial Results Adjusted EBITDA Consolidated Revenue Dermapharm Holding SE Branded Pharmaceuticals
PRESS RELEASE published on 03/14/2025 at 07:30, 1 year 4 months ago Steyr Motors confirms successful global business development strategy with further framework agreement from Brazil – Order backlog increases to almost EUR 200 million by 2027 Steyr Motors AG confirms successful global business development strategy with a new framework agreement from Brazil, increasing order backlog to nearly EUR 200 million by 2027 Growth Strategy Order Backlog Framework Agreement Global Business Steyr Motors AG
PRESS RELEASE published on 03/14/2025 at 07:30, 1 year 4 months ago Former DAX-CEO Kasper Rørsted joins AI-Robotics Company Circus SE Former DAX-CEO Kasper Rørsted joins AI-Robotics Company Circus SE to support global scale-up of Embodied AI robot for food service industry. Strategic expertise to redefine food production through robotics and AI Circus SE Food Production AI-Robotics Kasper Rørsted Embody AI
PRESS RELEASE published on 03/14/2025 at 07:30, 1 year 4 months ago Lenzing Group continued its recovery course in the 2024 financial year Lenzing Group's 2024 financial year shows revenue growth of 5.7% to EUR 2.66 bn, with EBITDA up 30.4% and free cash flow positive. CEO anticipates market challenges in 2025 EBITDA Revenue Growth Market Challenges 2024 Financial Year Lenzing Group
PRESS RELEASE published on 03/14/2025 at 07:30, 1 year 4 months ago Inside Information / News release on accounts, results Sensorion reports full-year 2024 results and provides corporate update with significant milestones achieved in gene therapy clinical trials and financial highlights. Company well positioned for growth in 2025 Clinical Trials Financial Highlights Gene Therapy Full-year Results Sensorion
PRESS RELEASE published on 03/14/2025 at 07:00, 1 year 4 months ago Swiss Life in 2024: fee result up 33% and net profit up 13% – “Swiss Life 2024” Group-wide programme successfully concluded Swiss Life reports strong financial results for 2024, with fee result up 33% and net profit up 13%. Successful conclusion of 'Swiss Life 2024' programme Financial Results Dividend 2024 Swiss Life Swiss Life 2024
PRESS RELEASE published on 03/14/2025 at 07:00, 1 year 4 months ago Implenia wins major rail project in Sweden Implenia awarded CHF 130 million contract by Swedish Transport Administration for 'East Link' railway project, enhancing travel in eastern Sweden. Project includes bridges, railway tracks, and refurbishment, scheduled for completion in 2031 Sweden Implenia Railway Project East Link Swedish Transport Administration
PRESS RELEASE published on 03/14/2025 at 07:00, 1 year 4 months ago BIOVERSYS ANNOUNCES REPORTING DATE FOR FULL-YEAR 2024 FINANCIAL RESULTS AND EVENT DETAILS BioVersys AG announces reporting date for full-year 2024 financial results and event details, including a conference call and webcast on March 26, 2025. The company focuses on developing novel antibacterial products for MDR bacteria Financial Results Conference Call BioVersys AG Antibacterial Products MDR Bacteria
REGULATED PRESS RELEASE published on 03/14/2025 at 07:00, 1 year 4 months ago Coach and Interparfums extend their partnership in the universe of fragrances until June 2031 Coach and Interparfums extend their fragrance partnership until June 2031, renewing the license and launching new products for brand development Interparfums Brand Development Coach Fragrance Partnership License Renewal
PRESS RELEASE published on 03/14/2025 at 06:59, 1 year 4 months ago Matador Secondary Private Equity AG: Matador generated a profit of CHF 6.3 million in the 2024 financial year and the net asset value increased by almost 12% Matador Secondary Private Equity AG reported a profit of CHF 6.3 million and a 12% increase in net asset value for the 2024 financial year. The company shows confidence in future successful financial performance Private Equity Net Asset Value Profit 2024 Financial Year Matador Secondary Private Equity AG
Published on 07/22/2026 at 15:00, 12 hours 14 minutes ago Karbon-X Secures Technical Advisory Engagement for Nature-Based Carbon Project in Libya
Published on 07/22/2026 at 15:00, 12 hours 14 minutes ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
Published on 07/22/2026 at 14:35, 12 hours 39 minutes ago Wi2Wi Reports Significant Manufacturing Yield Improvement in Q2 2026
Published on 07/22/2026 at 14:30, 12 hours 44 minutes ago As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola
Published on 07/23/2026 at 02:05, 1 hour 9 minutes ago JINRO Unveils First Global Campaign "My Favorite JINRO" with V of BTS
Published on 07/22/2026 at 23:58, 3 hours 16 minutes ago EQS-Adhoc: Deutsche Rohstoff AG: Increase in 2026 Guidance: EBITDA of approximately EUR 365 million expected
Published on 07/22/2026 at 22:20, 4 hours 54 minutes ago Quantinuum Appoints Chief Legal Officer and Chief People Officer
Published on 07/22/2026 at 21:01, 6 hours 13 minutes ago EQS-Adhoc: Correction of a release from 22/07/2026, 20:08 CET/CEST - FUCHS SE: Preliminary results for the first half of the year ahead of expectations and increase in the EBIT forecast for 2026
Published on 07/22/2026 at 18:19, 8 hours 55 minutes ago Covivio successfully places €500 million of 7-year European Green Bonds
Published on 07/22/2026 at 17:45, 9 hours 29 minutes ago Groupe CRIT : 2026 first half revenue: €1.67 billion (+2.3% on an organic basis).
Published on 07/22/2026 at 17:40, 9 hours 34 minutes ago Report on share repurchases from 15 to 21 July 2026
Published on 07/22/2026 at 08:03, 19 hours 11 minutes ago Availability of the 2026 Interim Results Report
Published on 07/22/2026 at 08:00, 19 hours 14 minutes ago Neoen launches construction of Narrogin Wind Farm in Western Australia after signing PPA with Synergy